Production of Medical Radioisotopes Without A Nuclear Reactor

The Pallas business case - between dream and reality

In June 2013, the Laka Foundation published The Pallas business case  ('between dream and reality', in Dutch). The report assesses the plans for a new nuclear research reactor which is said to be necessary for the production of medical radioisotopes. The reactor should be privately funded and enter operation in 2023. Laka raised serious concerns about the business case and fears that the government will step in at a later stage to salvage the project with public money.
This could be alright if there would be no alternatives for the production of medical radioisotopes but there are: See below the May 2010 Laka report: Medical Radioisotope Production Without A Nuclear Reactor.

Here you can find an English summary of the June 2013 report.

Reactors not necessary for the production of medical radioisotopes

(May 22, 2010) Medical imaging is one of the fastest growing disciplines in medicine. The development of innovative imaging modalities and radio-pharmaceuticals has improved the ability to study biological structures and functions in health and disease, and continues to contribute to the evolution of medical care.

Artificial radioisotopes, among which those for medical use, are mainly produced by research reactors.
Currently more than 80% of the medical radioisotopes are produced by research reactors. The remaining radioisotopes are made with particle accelerators, mostly with circular accelerators (cyclotrons) and sometimes with linear accelerators (linac), or by other methods. Medical isotope-production is used by the nuclear industry as PR for nuclear research reactors.

The Laka report is answering the key question: Is it possible to ban the use of research reactors for the production of medical radioisotopes?

The answer is Yes!

Radioisotope production with particle accelerators offers many advantages over production with a nuclear reactor:

  1. The volume of radioactive waste produced by cyclotrons is far less and much less hazardous than the radioactive waste of research reactors;
  2. The production is decentralized. Cyclotrons are located hospital-based, by which the delivery of pharmaceuticals to patients is much more secured. In addition the risk of transport accidents is practically zero;
  3. There are no risks due to nuclear-power accidents, because there is no need for controlled chain reactions;
  4. There is no risk for nuclear proliferation.

Download the research report (38 pages, 800kb).

An abridged Dutch version is available for download here.

This entry was posted on by .

About Stichting Laka

Het documentatie- en onderzoekscentrum kernenergie - Ketelhuisplein 43, Amsterdam - tel: 020-6168294 - mail: - Twitter: @LakaNieuws - FB: - Linkedin: company:stichting-laka - ActivityPub:

Related posts:


  • 6 May 2024: UK: Estimated cost of undersea nuclear graveyard now £66bn

    A vast subsea nuclear graveyard planned to hold Britain’s burgeoning piles of radioactive waste is set to become the biggest, longest-lasting and most expensive infrastructure project ever undertaken in the UK. The project [UK's nuclear waste dump] is now predicted to take more than 150yrs to complete with lifetime costs of £66bn in today’s money...The […]

  • 20 April 2024: Chemelot: SMR at Limburg chemical cluster undesirable

    Last year, the Dutch Province of Limburg started an alliance in which, besides the local government, research institutes, small nuclear reactor (SMR) developers, utilities, industrial customers and funders cooperated. With this "Limburg SMR alliance" Limburg  tried to lead the way towards an SMR in Limburg. The preferred site for a first SMR would be Chemelot, […]

  • 3 April 2024: France to produce tritium for nuclear weapons in EDF civilian nuclear reactors

    From the IPFM: During a visit to the Civaux nuclear power plant on 18 March 2024, France's Minister of the Armed Forces unveiled a plan to use the plant to produce tritium for the French nuclear weapons program. Civaux is a civilian power plant that belongs to and is operated by Electricité de France. According […]

  • 2 April 2024: EU and US doubled purchases of nuclear fuel & uranium from Russia in 2023

    An analysis by the Norwegian NGO Bellona of transborder trade operations with the customs code 840130 (irradiated fuel assemblies or fuel elements) show a more than twofold increase of import to EU countries of fresh nuclear fuel in cash terms – from 280 million Euros in 2022 to 686 million Euros in 2023. In physical […]

  • 1 April 2024: AFP: France eyes spent uranium plant to bypass Russia

    The French government has said it is "seriously" studying the option of building a plant to convert and enrich reprocessed uranium to cut its reliance on Russia following the invasion of Ukraine. The only plant in the world that currently converts reprocessed uranium for use in nuclear power plants is in Russia. "The option of […]

  • 21 March 2024: Jan vd Putte warns for Rosatom

    Jan vd Putte quickly changed from dressing as the pied piper at the protest during the IAEA nuclear power conference to warn for the Russian nuclear power conglomerate Rosatom and its role in Ukraine.